Notably, our group has recently shown that ODC inhibition turns toxic severe reactive astrocytes into beta-amyloid (Aβ)-detoxifying astrocytes in Alzheimer’s disease (AD) model and raised ODC inhibition as a promising therapeutic strategy for AD.6 This evidence concerns the gene ODC1 and early-onset autosomal dominant Alzheimer disease.